"Not too heavy, not too light" Haha --- got that right.

New Post Public Reply Private Reply Replies (2) Message Board
My69z MGK_2 #142683
577
"Not too heavy, not too light"
Haha --- got that right.

"They have attempted to copy it but were

"They attempted work arounds, but they were abject failures"

Aka: patents.

On NP:
He's a habitual lier.
*Claimed saving the company from bk.

It was Cytodyn of Mexico in bk. The 1st "Cytodyn" company, controlled by Allen D. Allen & that company never had Pro-140.

Allen & daughter later formed today's Cytodyn.
Back then, I posted all the court documents & different companies.

*He said while he was on BOD in '08, initially worked for free, because he wanted to 1st show he could bring value to the company.

Was absolute bullshit.
He had a Service Agreement & was paid $200k yearly. So yea, he wasn't a "paid BOD member" & working "for free".

Here's the sack kicker --- the Agreement allowed him 1 assistant, who was to be given 250k shares & a salary.

He hired his wife. Who later sued Cytodyn. I posted yrs ago & have all the 2008 SEC filings & etc
..etc..

* He told us syringe issues was the hold-up due to being plastic & 700mg -- a simple mfgr fix".

* He said addtl experts were hired to help with the BLA. That was far in advance of the total BLA fallout.

We still don't know who they were or even seen "them" referenced in the e-mails.

So far, another lie.

*He said he sold shares to pay Samsung & he "always suffer for the company". No SEC filings.

I posted he also bought a $800k house.
Included pics of it too.

His employment contract says what the DOJ pointed out --- to get awarded stock, all that was needed, was a submitted BLA. That was all he cared about.

DOJ also said NP/KK were both told for 2 yrs by the FDA, about the BLA.

There's more to add to it all, but even this is too much to say someone was simply sleep @ the wheel.

Habitual lier, self enduring, to advance personal agenda
& he knew KK was being crooked too.

Agree 100% that both had different reasons for what they did & it all got seriously out of hand.

Finding out why KK conviently turned into a piece of shit, will be interesting. My bet, they settled a Sealed agreement.

Get all of KK's forms of communications with Amy entity or individuals, within years of date X to date Xyz

My bet is a settlement in a few months & most importantly, also agree 100% the FDA is not holding LL back now for 2024 & frwd.

Also for the significant reason many pointed out:
LL for Chronic is not a direct threat to the industry.

And loving there are no others competition.
Like you said --- they tried, & as of Feb 2023, realized total ownership is out of the question due to those patents.

One thing always overlooked ---- the Patent office was & is not, on any FDA / pharma team.

A saving grace.

Having im sure knowing of the 5-7 years working on & seeing in 2023 the patents granted, now, LL Chronic route is beneficial to them.

FDA works with us, to rid the company (LL), of the fishy players.

Dr. J says he's confident can say & glad Cytodyn:
"finally has a collaborative relationship, with the FDA"

All that matters & absolutely outstanding.
Still sinking in.

See the trial design, & it's sunken.

Shall see....

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teamsters Secure Strong Contract for CA Waste Workers

Updated Category News Views 99

Teamsters Flex Muscles in So-Cal Sanitation Sector So here's one for the books: 700 Waste Management workers represented by Teamsters Local 396 just locked down a fresh collective bargaining agreement in Los Angeles and Orange counties. And let me tell you, this isn’t just another contract—it's a testament to what solidarity can wring out of a massive corporation. The...

Continue Reading
WuXi AppTec Boosts Guidance Amid Strong CRDMO Growth

Updated Category News Views 208

Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...

Continue Reading
Marc Jacobs Expansion: Bold Moves, Bigger Markets

Updated Category News Views 64

Marc Jacobs' Bold Move into Greater China There's a new gust blowing through the retail fashion industry, and it's coming from the partnership between WHP Global, G-III Apparel Group, and I.T Group. These seasoned players are betting big on Marc Jacobs to expand its footprint in the Greater China region. I can practically see the dollar signs in their eyes as they dive...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 133

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
United Vein Expands Vero Beach Network for Specialized Care

Updated Category News Views 175

Simplifying Vein Healthcare in Vero Beach Out of all the surprises life throws, leg cramps and bulging veins seem like small potatoes—until they're not. That's why folks in Vero Beach got a new lifeline today with the United Vein & Vascular Centers opening another clinic. At the crossroads of the 37th Street medical district, this place puts specialized vein care right...

Continue Reading
Trip.com Drives Sustainability with New Travel Impact Tool

Updated Category News Views 55

Sustainability Takes Center Stage in Travel Plans So here's the deal: Traveling isn't just about snapping pictures of breathtaking views or rounding up souvenirs anymore. These days, people are increasingly keen on ensuring their trips don't leave a hefty carbon footprint. With the release of Trip.com's 2026 Sustainable Travel Consumer Report, it's clear that the winds...

Continue Reading
Duke Energy's Battle Against Energy Vampires Heats Up

Updated Category News Views 248

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Continue Reading
EQS Group's Climate Goals Get SBTi Validation

Updated Category News Views 90

EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...

Continue Reading
SWI Compute's Bold Move: Transforming Power Into AI

Updated Category News Views 180

The Power Play: From Grid to AI If you think turning megawatts into money-making machines is a stretch, think again. SWI Compute is daringly striding into this territory with the launch of its NVIDIA AI factories in Europe, backed by a hefty 3.6 gigawatts of secured power capacity. It's not just talk; they've got the juice, both in electricity and ambition, to boot....

Continue Reading
Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

Updated Category News Views 68

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of Cheniere Energy Investments Over Time

Updated Category News Views 164

Understanding Cheniere Energy's Investment Growth Cheniere Energy (NYSE: LNG) has emerged as a strong performer in the market over the past decade and a half, delivering impressive returns that outstrip many indices. Investors have significantly benefited from the smart and strategic positioning of the company in the energy sector. Annual Returns of Cheniere Energy Over...

Continue Reading
Manhattan Bridge Capital Announces New Quarterly Dividend Plans

Updated Category News Views 96

Manhattan Bridge Capital Announces New Quarterly Dividend Plans Located in Great Neck, New York, Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) continues to demonstrate its commitment to returning value to its shareholders. The company recently announced a quarterly dividend of $0.115 per share, reaffirming its position in the competitive financial landscape. Understanding...

Continue Reading
Mural Oncology Shareholders Approve Acquisition by XRA 5 Corp

Updated Category News Views 205

Mural Oncology Shareholders Approve Acquisition by XRA 5 Corp Mural Oncology plc (NASDAQ: MURA), a leader in developing immunotherapies, has secured significant approval from its shareholders regarding a pivotal acquisition by XRA 5 Corp., a subsidiary of XOMA Royalty Corporation (NASDAQ: XOMA). During recent shareholder meetings, the overwhelming majority endorsed the...

Continue Reading
ARTIS Zoo's New Certification: A Win for Urban Wildlife

Updated Category News Views 208

A New Dawn for Nocturnal Wildlife at ARTIS Zoo Next to a vibrant scene, Amsterdam now boasts a remarkable dark zone. Royal Zoo ARTIS has proudly earned the title of Urban Night Sky Place from DarkSky International. This landmark achievement marks ARTIS as the first zoo within a European capital to receive such an honor, and it stands out as the first zoo worldwide to...

Continue Reading
iBio Secures Board Investments to Boost Obesity Treatments

Updated Category News Views 156

iBio Secures Major Investments from Leadership In a recent announcement, iBio, Inc. has revealed that it has successfully closed a private placement offering with prominent members of its Board of Directors and corporate officers, amassing over $650,000 in funding. This significant financial backing highlights the confidence that the board members have in iBio's vision...

Continue Reading